Prognostic value of blood flow measurements using arterial spin labeling in gliomas.

The period of event-free survival (EFS) within the same histopathological glioma grades may have high variability, mainly without a known cause. The purpose of this study was to reveal the prognostic value of quantified tumor blood flow (TBF) values obtained by arterial spin labeling (ASL) for EFS i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Julia Furtner, Benjamin Bender, Christian Braun, Jens Schittenhelm, Marco Skardelly, Ulrike Ernemann, Sotirios Bisdas
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e29881dcdcc14ae28db2c2cf291273c8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e29881dcdcc14ae28db2c2cf291273c8
record_format dspace
spelling oai:doaj.org-article:e29881dcdcc14ae28db2c2cf291273c82021-11-18T08:16:38ZPrognostic value of blood flow measurements using arterial spin labeling in gliomas.1932-620310.1371/journal.pone.0099616https://doaj.org/article/e29881dcdcc14ae28db2c2cf291273c82014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24911025/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203The period of event-free survival (EFS) within the same histopathological glioma grades may have high variability, mainly without a known cause. The purpose of this study was to reveal the prognostic value of quantified tumor blood flow (TBF) values obtained by arterial spin labeling (ASL) for EFS in patients with histopathologically proven astrocytomas independent of WHO (World Health Organization) grade. Twenty-four patients with untreated gliomas underwent tumor perfusion quantification by means of pulsed ASL in 3T. The clinical history of the patients was retrospectively extracted from the local database. Six patients had to be excluded due to insufficent follow-up data for further evaluation or histopathologically verified oligodendroglioma tumor components. Receiver operating characteristic (ROC) curves were used to define an optimal cut-off value of maximum TBF (mTBF) values for subgrouping in low-perfused and high-perfused gliomas. Kaplan-Meier curves and Cox proportional hazard regression model were used to determine the prognostic value of mTBF for EFS. An optimal mTBF cut-off value of 182 ml/100 g/min (sensitivity  = 83%, specificity  = 100%) was determined. Patients with low-perfused gliomas had significantly longer EFS compared to patients with high-perfused gliomas (p = 0.0012) independent of the WHO glioma grade. Quantified mTBF values obtained by ASL offer a new and totally non-invasive marker to prognosticate the EFS, independently on histopathological tumor grading, in patients with gliomas.Julia FurtnerBenjamin BenderChristian BraunJens SchittenhelmMarco SkardellyUlrike ErnemannSotirios BisdasPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 6, p e99616 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Julia Furtner
Benjamin Bender
Christian Braun
Jens Schittenhelm
Marco Skardelly
Ulrike Ernemann
Sotirios Bisdas
Prognostic value of blood flow measurements using arterial spin labeling in gliomas.
description The period of event-free survival (EFS) within the same histopathological glioma grades may have high variability, mainly without a known cause. The purpose of this study was to reveal the prognostic value of quantified tumor blood flow (TBF) values obtained by arterial spin labeling (ASL) for EFS in patients with histopathologically proven astrocytomas independent of WHO (World Health Organization) grade. Twenty-four patients with untreated gliomas underwent tumor perfusion quantification by means of pulsed ASL in 3T. The clinical history of the patients was retrospectively extracted from the local database. Six patients had to be excluded due to insufficent follow-up data for further evaluation or histopathologically verified oligodendroglioma tumor components. Receiver operating characteristic (ROC) curves were used to define an optimal cut-off value of maximum TBF (mTBF) values for subgrouping in low-perfused and high-perfused gliomas. Kaplan-Meier curves and Cox proportional hazard regression model were used to determine the prognostic value of mTBF for EFS. An optimal mTBF cut-off value of 182 ml/100 g/min (sensitivity  = 83%, specificity  = 100%) was determined. Patients with low-perfused gliomas had significantly longer EFS compared to patients with high-perfused gliomas (p = 0.0012) independent of the WHO glioma grade. Quantified mTBF values obtained by ASL offer a new and totally non-invasive marker to prognosticate the EFS, independently on histopathological tumor grading, in patients with gliomas.
format article
author Julia Furtner
Benjamin Bender
Christian Braun
Jens Schittenhelm
Marco Skardelly
Ulrike Ernemann
Sotirios Bisdas
author_facet Julia Furtner
Benjamin Bender
Christian Braun
Jens Schittenhelm
Marco Skardelly
Ulrike Ernemann
Sotirios Bisdas
author_sort Julia Furtner
title Prognostic value of blood flow measurements using arterial spin labeling in gliomas.
title_short Prognostic value of blood flow measurements using arterial spin labeling in gliomas.
title_full Prognostic value of blood flow measurements using arterial spin labeling in gliomas.
title_fullStr Prognostic value of blood flow measurements using arterial spin labeling in gliomas.
title_full_unstemmed Prognostic value of blood flow measurements using arterial spin labeling in gliomas.
title_sort prognostic value of blood flow measurements using arterial spin labeling in gliomas.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/e29881dcdcc14ae28db2c2cf291273c8
work_keys_str_mv AT juliafurtner prognosticvalueofbloodflowmeasurementsusingarterialspinlabelingingliomas
AT benjaminbender prognosticvalueofbloodflowmeasurementsusingarterialspinlabelingingliomas
AT christianbraun prognosticvalueofbloodflowmeasurementsusingarterialspinlabelingingliomas
AT jensschittenhelm prognosticvalueofbloodflowmeasurementsusingarterialspinlabelingingliomas
AT marcoskardelly prognosticvalueofbloodflowmeasurementsusingarterialspinlabelingingliomas
AT ulrikeernemann prognosticvalueofbloodflowmeasurementsusingarterialspinlabelingingliomas
AT sotiriosbisdas prognosticvalueofbloodflowmeasurementsusingarterialspinlabelingingliomas
_version_ 1718422017376518144